Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment

Neuroscience Letters

Volumn 562, Issue , 2014, Pages 1-6

  Zhang, Yanwei ^a,b   Zhang, Xiao ^a   Zhang, Jiuquan ^a   Liu, Chen ^a   Yuan, Qiaoying ^a   Yin, Xuntao ^a   Wei, Luqing ^a   Cui, Jinguo ^b   Tao, Ran ^a,b   Wei, Ping ^a   Wang, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Gray matter; Mild cognitive impairment; Type 2 diabetes mellitus; Voxel based morphometry

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ANGULAR GYRUS; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CUNEUS; DIABETIC PATIENT; FEMALE; FUSIFORM GYRUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; INFERIOR PARIETAL LOBULE; LIMBIC SYSTEM; MALE; MIDDLE AGED; MIDDLE FRONTAL GYRUS; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL GYRUS; PARAHIPPOCAMPAL GYRUS; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; TEMPORAL LOBE; UNCUS; VOXEL BASED MORPHOMETRY;

GRAY MATTER; MILD COGNITIVE IMPAIRMENT; TYPE 2 DIABETES MELLITUS; VOXEL-BASED MORPHOMETRY;

ADULT; AGED; ATROPHY; BRAIN; BRAIN MAPPING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT;

EID: 84892953226     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.006     Document Type: Article

References (31)

1. Ashburner J. Computational anatomy with the SPM software. Magn. Reson. Imaging 2009, 27:1163-1174.
2. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11:805-821.
3. Association A.D. Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl. 1):S11-S61.
4. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008, 7:184-190.
5. Bruce D.G., Casey G.P., Grange V., Clarnette R.C., Almeida O.P., Foster J.K., Ives F.J., Davis T.M. Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes Res. Clin. Pract. 2003, 61:59-67.
6. Brundel M., van den Heuvel M., de Bresser J., Kappelle L.J., Biessels G.J. Cerebral cortical thickness in patients with type 2 diabetes. J. Neurol. Sci. 2010, 299:126-130.
7. Chao-Gan Y., Yu-Feng Z. DPARSF: a MATLAB toolbox for "Pipeline" data analysis of resting-state fMRI. Front. Syst. Neurosci. 2010, 4:13.
8. Chen Z., Li L., Sun J., Ma L. Mapping the brain in type II diabetes: voxel-based morphometry using DARTEL. Eur. J. Radiol. 2012, 81:1870-1876.
9. den Heijer T., Vermeer S.E., van Dijk E.J., Prins N.D., Koudstaal P.J., Hofman A., Breteler M.M.B. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003, 46:1604-1610.
10. Ebady S.A., Arami M.A., Shafigh M.H. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res. Clin. Pract. 2008, 82:305-309.
11. Fox M.D., Corbetta M., Snyder A.Z., Vincent J.L., Raichle M.E. Spontaneous neuronal activity distinguishes human dorsal and ventral attention systems. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10046-10051.
12. Gold S.M., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 2007, 50:711-719.
13. Hamalainen A., Tervo S., Grau-Olivares M., Niskanen E., Pennanen C., Huuskonen J., Kivipelto M., Hanninen T., Tapiola M., Vanhanen M., Hallikainen M., Helkala E.-L., Nissinen A., Vanninen R., Soininen H. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment. Neuroimage 2007, 37:1122-1131.
14. Hunderfund A.L., Roberts R.O., Slusser T.C., Leibson C.L., Geda Y.E., Ivnik R.J., Tangalos E.G., Petersen R.C. Mortality in amnestic mild cognitive impairment: a prospective community study. Neurology 2006, 67:1764-1768.
15. Karas G.B., Scheltens P., Rombouts S.A., Visser P.J., van Schijndel R.A., Fox N.C., Barkhof F. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004, 23:708-716.
16. Korf E.S.C., White L.R., Scheltens P., Launer L.J. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 2006, 29:2268-2274.
17. Last D., Alsop D.C., Abduljalil A.M., Marquis R.P., de Bazelaire C., Hu K., Cavallerano J., Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007, 30:1193-1199.
18. Lee J.Y., Dong Woo L., Cho S.J., Na D.L., Hong Jin J., Kim S.K., You Ra L., Youn J.H., Kwon M., Lee J.H., Maeng Je C. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J. Geriatr. Psychiatry Neurol. 2008, 21:104-110.
19. Luchsinger J.A. Diabetes, related conditions, and dementia. J. Neurol. Sci. 2010, 299:35-38.
20. McCrimmon R.J., Ryan C.M., Frier B.M. Diabetes and cognitive dysfunction. Lancet 2012.
21. Moran C., Phan T.G., Chen J., Blizzard L., Beare R., Venn A., Munch G., Wood A.G., Forbes J., Greenaway T.M., Pearson S., Srikanth V. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013, 36:4036-4042.
22. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin. Neurol. 2007, 27:22-31.
23. Portet F., Ousset P.J., Visser P.J., Frisoni G.B., Nobili F., Scheltens P., Vellas B., Touchon J. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2006, 77:714-718.
24. Ray M., Zhang W. Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks. BMC Syst. Biol. 2010, 4:136.
25. Spauwen P.J., Kohler S., Verhey F.R., Stehouwer C.D., van Boxtel M.P. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care. 2013, 36:1554-1561.
26. Umegaki H., Iimuro S., Shinozaki T., Araki A., Sakurai T., Iijima K., Ohashi Y., Ito H. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese Elderly Diabetes Intervention Trial. Geriatr. Gerontol. Int. 2012, 12(Suppl. 1):110-116.
27. Whitney K.A., Mossbarger B., Herman S.M., Ibarra S.L. Is the Montreal cognitive assessment superior to the mini-mental state examination in detecting subtle cognitive impairment among middle-aged outpatient U.S. Military veterans?. Arch. Clin. Neuropsychol.: Off. J. Natl. Acad. Neuropsychol. 2012, 27:742-748.
28. Xia W., Wang S., Sun Z., Bai F., Zhou Y., Yang Y., Wang P., Huang Y., Yuan Y. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology. 2013, 38:2493-2501.
29. Xu W.L., von Strauss E., Qiu C.X., Winblad B., Fratiglioni L. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia 2009, 52:1031-1039.
30. Zetterberg H., Blennow K., Hanse E. Amyloid beta and APP as biomarkers for Alzheimer's disease. Exp. Gerontol. 2010, 45:23-29.
31. Zhou H., Lu W.J., Zhang Z.J., Bai F., Chang J.H., Teng G.J. Study of cognitive function and brain volume in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2010, 90:327-331.